Inventor · disambiguated record
Mark A. Tomai
Also filed as: TOMAI MARK · TOMAI MARK A
15 granted patents·25 pending applications·2,927 citations·filing 1994–2021
96Inventor score
Files with3M INNOVATIVE PROPERTIES CO313M INNOVATIVE PROPERTIES COMPANY2CHILDRENS MEDICAL CENTER1KINDEVA DRUG DELIVERY LP1LEVY OFER1
Top patents by PatentIndex Score
40 records- 0198US6376669B1Dye labeled imidazoquinoline compounds3M INNOVATIVE PROPERTIES CO·Filed 2000·Granted Apr 23, 2002·378 cites·11 claims
- 0297US6558951B1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 1999·Granted May 6, 2003·342 cites·10 claims
- 0397US6200592B1Immine response modifier compounds for treatment of TH2 mediated and related diseases3M INNOVATIVE PROPERTIES CO·Filed 2000·Granted Mar 13, 2001·274 cites·7 claims
- 0497US6039969AImmune response modifier compounds for treatment of TH2 mediated and related diseases3M INNOVATIVE PROPERTIES CO·Filed 1997·Granted Mar 21, 2000·516 cites·12 claims
- 0596US6696076B2Immune response modifier compounds for treatment of TH2 mediated and related diseases3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Feb 24, 2004·171 cites·11 claims
- 0696US6630588B2Dye labeled imidazoquinoline compounds3M INNOVATIVE PROPERTIES CO·Filed 2002·Granted Oct 7, 2003·66 cites·3 claims
- 0796US6610319B2Immune response modifier compounds for treatment of TH2 mediated and related diseases3M INNOVATIVE PROPERTIES CO·Filed 2000·Granted Aug 26, 2003·111 cites·1 claims
- 0896US5939090AGel formulations for topical drug delivery3M INNOVATIVE PROPERTIES CO·Filed 1996·Granted Aug 17, 1999·379 cites·13 claims
- 0995US7226928B2Methods for the treatment of periodontal disease3M INNOVATIVE PROPERTIES CO·Filed 2002·Granted Jun 5, 2007·69 cites·7 claims
- 1095US6916925B1Dye labeled imidazoquinoline compounds3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Jul 12, 2005·67 cites·5 claims
- 1195US6083505A1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants3M INNOVATIVE PROPERTIES CO·Filed 1994·Granted Jul 4, 2000·417 cites·16 claims
- 1292US6365166B2Gel formulations for topical drug delivery3M INNOVATIVE PROPERTIES CO·Filed 1999·Granted Apr 2, 2002·130 cites·7 claims
- 1389US9801947B2Methods and compositions for enhancing immune response3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Oct 31, 2017·7 cites·20 claims
- 1460US2008193468A1Method for Stimulating the Immune Response of NewbornsCHILDRENS MEDICAL CENTER·Filed 2005·Application pending·0 cites
- 1560US2004265351A1Methods and compositions for enhancing immune responseFiled 2004·Application pending·0 cites
- 1660US2017319712A1Methods and compositions for enhancing immune response3M INNOVATIVE PROPERTIES CO·Filed 2017·Application pending·0 cites
- 1757US2005158325A1Immunomodulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 1856US2023406855A1N-1 branched imidazoquinolines, conjugates thereof, and methods3M INNOVATIVE PROPERTIES COMPANY·Filed 2021·Application pending·0 cites
- 1955US2023346954A1N-1 branched imidazoquinolines, conjugates thereof, and methods3M INNOVATIVE PROPERTIES COMPANY·Filed 2021·Application pending·0 cites
- 2054US12099046B2Manufacturing a biologic pharmaceutical using causal modelsSOLVENTUM INTELLECTUAL PROPERTIES COMPANY·Filed 2019·Granted Sep 24, 2024·0 cites·17 claims
- 2153US2022189632A1Individualized medicine using causal models3M INNOVATIVE PROPERTIES CO·Filed 2019·Application pending·0 cites
- 2250US2006009482A1Screening method for identifying compounds that selectively induce interferon alpha3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 2349US2005245564A1Methods and compositions related to IRM compounds and toll-like receptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 2449US2005239735A1Enhancement of immune responses3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 2549US2022241458A1Removable Film-Forming Gel Compositions Featuring Adhesion PromotersKINDEVA DRUG DELIVERY LP·Filed 2020·Application pending·0 cites
- 2648US2003186440A1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 2003·Application pending·0 cites
- 2748US2009246174A1Treatment for cutaneous t cell lymphomaROOK ALAIN H·Filed 2006·Application pending·0 cites
- 2847US2005096259A1Neutrophil activation by immune response modifier compounds3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 2947US2015110784A1Therapeutic combinations and methods including irm compounds3M INNOVATIVE PROPERTIES CO·Filed 2014·Application pending·0 cites
- 3047US2004014779A1Methods and compositions related to IRM compounds and toll-like recptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2002·Application pending·0 cites
- 3146US2005048072A1Immunostimulatory combinations and treatments3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 3246US2002110840A1Screening method for identifying compounds that selectively induce interferon alpha3M INNOVATIVE PROPERTIES CO·Filed 2001·Application pending·0 cites
- 3345US2022172830A1Controlling hospital operations using causal models3M INNOVATIVE PROPERTIES CO·Filed 2019·Application pending·0 cites
- 3445US2004242620A1Immune response modifier compounds for treatment of TH2 mediated and related diseases3M INNOVATIVE PROPERTIES CO·Filed 2003·Application pending·0 cites
- 3545US2017340612A1Treatment for cutaneous t cell lymphoma3M INNOVATIVE PROPERTIES CO·Filed 2017·Application pending·0 cites
- 3645US2022180979A1Adaptive clinical trials3M INNOVATIVE PROPERTIES CO·Filed 2019·Application pending·0 cites
- 3744US2005226878A1Therapeutic combinations and methods including IRM compounds3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 3843US8940755B2Therapeutic combinations and methods including IRM compoundsTOMAI MARK A·Filed 2004·Granted Jan 27, 2015·0 cites·13 claims
- 3943US2012128715A1Method for stimulating the immune response of newbornsLEVY OFER·Filed 2012·Application pending·0 cites
- 4041US2003133913A1Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules3M INNOVATIVE PROPERTIES CO·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark A. Tomai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →